[1] C.P. Denton, D. Khanna, Systemic sclerosis, Lancet 390 (2017) 1685–1699.
[2] O. Ishikawa, H. Ishikawa, Macrophage infiltration in the skin of patients with systemic sclerosis, J. Rheumatol. 19 (1992) 1202–1206.
[3] D. Abraham, O. Distler, How does endothelial cell injury start? The role of endothelin in systemic sclerosis, Arthritis Res. Ther. 9 (2007) S2.
[4] J.Y. Luo, X. Liu, M. Jiang, H.P. Zhao, J.J. Zhao, Oxidative stress markers in blood in systemic sclerosis: a meta-analysis, Mod. Rheumatol. 27 (2017) 306–314.
[5] S. Motegi, S. Toki, K. Yamada, A. Uchiyama, O. Ishikawa, Elevated plasma homocysteine level is possibly associated with skin sclerosis in a series of Japanese patients with systemic sclerosis, J. Dermatol. 41 (2014) 986–991.
[6] A. Servettaz, C. Goulvestre, N. Kavian, C. Nicco, P. Guilpain, C. Chéreau, et al., Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse, J. Immunol. 182 (2009) 5855–5864.
[7] A. Yoshizaki, K. Yanaba, A. Ogawa, Y. Iwata, F. Ogawa, M. Takenaka, et al., The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin- induced and tight skin mouse models of systemic sclerosis, Arthritis Rheum. 63 (2011) 3086–3097.
[8] S. Piera-Velazquez, S.A. Jimenez, Role of cellular senescence and NOX4- mediatedoxidative stress in systemic sclerosis pathogenesis, Curr. Rheumatol. Rep. 17 (2015) 473.
[9] S.M. Somerset, L. Johannot, Dietary flavonoid sources in Australian adults, Nutr. Cancer 60 (2008) 442–449.
[10] M. Erben-Russ, W. Bors, M. Saran, Reactions of linoleic acid peroxyl radicals with phenolic antioxidants: a pulse radiolysis study, Int. J. Radiat. Relat. Stud. Phys. Chem. Med. 52 (1987) 393–412.
[11] I. Crespo, M.V. García-Mediavilla, B. Gutiérrez, S. Sánchez-Campos, M.J. Tuñón, J. González-Gallego, A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells, Br. J. Nutr. 100 (2008) 968–976.
[12] E.J. Yang, G.S. Kim, M. Jun, K.S. Song, Kaempferol attenuates the glutamate- induced oxidative stress in mouse-derived hippocampal neuronal HT22 cells, Food Funct. 5 (2014) 1395–1402.
[13] I. Crespo, M.V. García-Mediavilla, M. Almar, P. González, M.J. Tuñón, S. Sánchez-Campos, et al., Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells, Food Chem. Toxicol. 46 (2008) 1555–1569.
[14] P. Rajendran, T. Rengarajan, N. Nandakumar, R. Palaniswami, Y. Nishigaki, I. Nishigaki, Kaempferol, a potential cytostatic and cure for inflammatory disorders, Eur. J. Med. Chem. 86 (2014) 103–112.
[15] Q. Dang, W. Song, D. Xu, Y. Ma, F. Li, J. Zeng, et al., Kaempferol suppresses bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis, Mol. Carcinog. 54 (2015) 831–840.
[16] Y. Yokoyama, A. Sekiguchi, C. Fujiwara, A. Uchiyama, A. Uehara, S. Ogino, et al., Inhibitory regulation of skin fibrosis in systemic sclerosis by Apelin/APJ signaling, Arthritis Rheumatol. 70 (2018) 1661–1672.
[17] C. Fujiwara, A. Uehara, A. Sekiguchi, A. Uchiyama, S. Yamazaki, S. Ogino, et al., Suppressive regulation by MFG-E8 of latent transforming growth factor β- Induced fibrosis via binding to αv integrin: significance in the pathogenesis of fibrosis in systemic sclerosis, Arthritis Rheumatol. 71 (2019) 302–314.
[18] N.M. Thoua, E.C. Derrett-Smith, K. Khan, A. Dooley, X. Shi-Wen, C.P. Denton, Gut fibrosis with altered colonic contractility in a mouse model of scleroderma, Rheumatology (Oxford) 51 (2012) 1989–1998.
[19] D. Oikawa, R. Akai, M. Tokuda, T. Iwawaki, A transgenic mouse model for monitoring oxidative stress, Sci. Rep. 2 (2012) 229.
[20] S. Motegi, A. Sekiguchi, A. Uchiyama, A. Uehara, C. Fujiwara, S. Yamazaki, et al., Protective effect of mesenchymal stem cells on the pressure ulcer formation by the regulation of oxidative and endoplasmic reticulum stress, Sci. Rep. 7 (2017) 17186.
[21] A. Sekiguchi, S. Motegi, A. Uchiyama, A. Uehara, C. Fujiwara, S. Yamazaki, et al., Botulinum toxin B suppresses the pressure ulcer formation in cutaneous ischemia-reperfusion injury mouse model: possible regulation of oxidative and endoplasmic reticulum stress, J. Dermatol. Sci. 90 (2018) 144–153.
[22] A. Uchiyama, K. Yamada, B. Perera, S. Ogino, Y. Yokoyama, Y. Takeuchi, et al., Topical betamethasone butyrate propionate exacerbates pressure ulcers after cutaneous ischemia-reperfusion injury, Exp. Dermatol. 25 (2016) 678–683.
[23] A. Uchiyama, K. Yamada, B. Perera, S. Ogino, Y. Yokoyama, Y. Takeuchi, et al., Protective effect of MFG-E8 after cutaneous ischemia-reperfusion injury, J. Invest. Dermatol. 135 (2015) 1157–1165.
[24] E.C. LeRoy, C. Black, R. Fleischmajer, S. Jablonska, T. Krieg, T.A. Medsger Jr, et al., Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J. Rheumatol. 15 (1988) 202–205.
[25] S. Motegi, A. Uchiyama, K. Yamada, S. Ogino, Y. Yokoyama, B. Perera, et al., Increased susceptibility to oxidative stress- and ultraviolet A-induced apoptosis in fibroblasts in atypical progeroid syndrome/atypical Werner syndrome with LMNA mutation, Exp. Dermatol. 25 (Suppl. 3) (2016) 20–27.
[26] C.P. Denton, D.J. Abraham, Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis, Curr. Opin. Rheumatol. 13 (2001) 505–511.
[27] K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, et al., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, Biochem. Biophys. Res. Commun. 236 (1997) 313–322.
[28] J. Alam, D. Stewart, C. Touchard, S. Boinapally, A.M. Choi, J.L. Cook, Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene, J. Biol. Chem. 274 (1999) 26071–26078.
[29] K. Bedard, K.H. Krause, The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology, Physiol. Rev. 87 (2007) 245–313.
[30] T. Tanaka, F. Hosoi, Y. Yamaguchi-Iwai, H. Nakamura, H. Masutani, S. Ueda, et al., Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria- dependent apoptosis, EMBO J. 21 (2002) 1695–1703.
[31] T. Yamamoto, The bleomycin-inducedscleroderma model:whathavewelearned for scleroderma pathogenesis? Arch. Dermatol. Res. 297 (2006) 333–344.
[32] L. Kong, C. Luo, X. Li, Y. Zhou, H. He, The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits, Lipids Health Dis. 12 (2013) 115.
[33] P.S. Tsou, N.M. Talia, A.J. Pinney, A. Kendzicky, S. Piera-Velazquez, S.A. Jimenez, et al., Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts, Arthritis Rheum. 64 (2012) 1978–1989.
[34] T. Spadoni, S. Svegliati Baroni, D. Amico, L. Albani, G. Moroncini, E.V. Avvedimento, et al., A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis, Arthritis Rheumatol. 67 (2015) 1611–1622.
[35] T. Toyama, A.P. Looney, B.M. Baker, L. Stawski, P. Haines, R. Simms, et al., Therapeutic targeting of TAZ and YAP by dimethyl fumarate in systemic sclerosis fibrosis, J. Invest. Dermatol. 138 (2018) 78–88.
[36] A. Dooley, X. Shi-Wen, N. Aden, T. Tranah, N. Desai, C.P. Denton, et al., Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate, Rheumatology (Oxford) 49 (2010) 2024–2036.
[37] R. Cao, K. Fu, X. Lv, W. Li, N. Zhang, Protective effects of kaempferol on lipopolysaccharide-induced mastitis in mice, Inflammation 37 (2014) 1453–1458.
[38] S. Pendyala, I.A. Gorshkova, P.V. Usatyuk, D. He, A. Pennathur, J.D. Lambeth, et al., Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells, Antioxid. Redox Signal. 11 (2009) 747–764.
[39] P. Sambo, S.S. Baroni, M. Luchetti, P. Paroncini, S. Dusi, G. Orlandini, et al., Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway, Arthritis Rheum. 44 (2001) 2653–2664.
[40] S. Svegliati, R. Cancello, P. Sambo, M. Luchetti, P. Paroncini, G. Orlandini, et al., Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts, J. Biol. Chem. 280 (2005) 36474– 36482.
[41] Q. Xu, S. Choksi, J. Qu, J. Jang, M. Choe, B. Banfi, et al., NADPH oxidases are essential for macrophage differentiation, J. Biol. Chem. 291 (2016) 20030– 20041.
[42] D. Amico, T. Spadoni, M. Rovinelli, M. Serafini, G. D’Amico, N. Campelli, et al., Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2, Arthritis Res. Ther. 17 (2015) 68.
[43] P. Cheresh, S.J. Kim, S. Tulasiram, D.W. Kamp, Oxidative stress and pulmonary fibrosis, Biochim. Biophys. Acta 1832 (2013) 1028–1040.
[44] M. Jiang, Y. Yu, J. Luo, Q. Gao, L. Zhang, Q. Wang, et al., Bone marrow-derived mesenchymal stem cells expressing thioredoxin 1 attenuate bleomycin- induced skin fibrosis and oxidative stress in scleroderma, J. Invest. Dermatol. 137 (2017) 1223–1233.
[45] M. Kaulich, F. Streicher, R. Mayer, I. Müller, C.E. Müller, Flavonoids-novel lead compounds for the development of P2Y2 receptor antagonists, Drug Dev. Res. 59 (2003) 72–81.
[46] C. Séror, M.T. Melki, F. Subra, S.Q. Raza, M. Bras, H. Saïdi, et al., Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection, J. Exp. Med. 208 (2011) 1823–1834.
[47] D. Lu, P.A. Insel, Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis, Am. J. Physiol., Cell Physiol. 306 (2014) C779–C788.
[48] T. Takahashi, Y. Kimura, K. Niwa, Y. Ohmiya, T. Fujimura, K. Yamasaki, et al., In vivo imaging demonstrates ATP release from murine keratinocytes and its involvement in cutaneous inflammation after tape stripping, J. Invest. Dermatol. 133 (2013) 2407–2415.
[49] K. Tanaka, J. Choi, Y. Cao, G. Stacey, Extracellular ATP acts as a damage- associated molecular pattern (DAMP) signal in plants, Front. Plant Sci. 5 (2014) 446.
[50] L.M.B. Perera, A. Sekiguchi, A. Uchiyama, A. Uehara, C. Fujiwara, S. Yamazaki, et al., The regulation of skin fibrosis in systemic sclerosis by extracellular ATP via P2Y2 purinergic receptor, J. Invest. Dermatol. 139 (2019) 890–899.